Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
epidermolysis bullosa
Pharma
Krystal Biotech's Vyjuvek launch sparks blockbuster hopes
In its first six months of U.S. commercial availability, Krystal's topical gene therapy Vyjuvek raked in more than $50 million.
Zoey Becker
Feb 26, 2024 2:41pm
FDA blesses Chiesi’s Filsuvez for rare skin disease EB
Dec 20, 2023 8:20am
Krystal's Vyjuvek becomes first topical gene therapy
May 19, 2023 5:06pm